Kestra Medical Technologies (KMTS) Amortization of Deferred Charges (2024 - 2026)
Kestra Medical Technologies (KMTS) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $469000.0 as the latest value for Q1 2026.
- Quarterly Amortization of Deferred Charges rose 98.73% to $469000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Jan 2026, up 51.58% year-over-year, with the annual reading at $1.4 million for FY2025, 129.51% up from the prior year.
- Amortization of Deferred Charges for Q1 2026 was $469000.0 at Kestra Medical Technologies, roughly flat from $468000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $501000.0 in Q2 2024, with the low at $82000.0 in Q1 2024.
- Average Amortization of Deferred Charges over 3 years is $336444.4, with a median of $369000.0 recorded in 2025.
- Peak annual rise in Amortization of Deferred Charges hit 187.8% in 2025, while the deepest fall reached 26.35% in 2025.
- Over 3 years, Amortization of Deferred Charges stood at $234000.0 in 2024, then soared by 100.0% to $468000.0 in 2025, then increased by 0.21% to $469000.0 in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $469000.0, $468000.0, and $469000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.